JP2006505290A5 - - Google Patents

Download PDF

Info

Publication number
JP2006505290A5
JP2006505290A5 JP2005506685A JP2005506685A JP2006505290A5 JP 2006505290 A5 JP2006505290 A5 JP 2006505290A5 JP 2005506685 A JP2005506685 A JP 2005506685A JP 2005506685 A JP2005506685 A JP 2005506685A JP 2006505290 A5 JP2006505290 A5 JP 2006505290A5
Authority
JP
Japan
Prior art keywords
peroxiredoxin
fragment
pharmaceutical composition
vihum
prx
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2005506685A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006505290A (ja
Filing date
Publication date
Priority claimed from RU2002129774/15A external-priority patent/RU2280448C2/ru
Priority claimed from RU2003123534/13A external-priority patent/RU2250262C1/ru
Application filed filed Critical
Priority claimed from PCT/RU2003/000473 external-priority patent/WO2004043485A1/ru
Publication of JP2006505290A publication Critical patent/JP2006505290A/ja
Publication of JP2006505290A5 publication Critical patent/JP2006505290A5/ja
Pending legal-status Critical Current

Links

JP2005506685A 2002-11-10 2003-11-05 抗酸化医薬化合物、ポリペプチドの産生方法、治療方法 Pending JP2006505290A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2002129774/15A RU2280448C2 (ru) 2002-11-10 2002-11-10 Композиция с антиоксидантными свойствами и способ лечения болезней млекопитающих
RU2003123534/13A RU2250262C1 (ru) 2003-07-29 2003-07-29 РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pET23-a(+)PrxVIhumΔ178, КОДИРУЮЩАЯ N-КОНЦЕВОЙ ФРАГМЕНТ ПЕРОКСИРЕДОКСИНА VI ЧЕЛОВЕКА, И ШТАММ E.coli BL21/DE3/pET23-a(+)/PrxVIhumΔ178 - ПРОДУЦЕНТ N-КОНЦЕВОГО ФРАГМЕНТА ПЕРОКСИРЕДОКСИНА VI ЧЕЛОВЕКА
PCT/RU2003/000473 WO2004043485A1 (en) 2002-11-10 2003-11-05 Antioxidant pharmaceutical compound, method for producing polypeptide and method of cure

Publications (2)

Publication Number Publication Date
JP2006505290A JP2006505290A (ja) 2006-02-16
JP2006505290A5 true JP2006505290A5 (enExample) 2006-12-21

Family

ID=32314175

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005506685A Pending JP2006505290A (ja) 2002-11-10 2003-11-05 抗酸化医薬化合物、ポリペプチドの産生方法、治療方法

Country Status (5)

Country Link
US (1) US8003345B2 (enExample)
EP (1) EP1566182A4 (enExample)
JP (1) JP2006505290A (enExample)
CA (1) CA2505478A1 (enExample)
WO (1) WO2004043485A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012519652A (ja) * 2009-03-05 2012-08-30 国立大学法人福井大学 黄斑変性症または網膜症の予防または治療法
JP2012521355A (ja) * 2009-03-20 2012-09-13 ザ ジェネラル ホスピタル コーポレイション ディー ビー エイ マサチューセッツ ジェネラル ホスピタル 熱傷及び二次性合併症の予防及び治療方法
WO2011018472A2 (en) * 2009-08-14 2011-02-17 Basf Se Methods in cell cultures, and related inventions, employing certain additives
KR101336784B1 (ko) * 2010-10-25 2013-12-04 한국원자력연구원 방사선 조사를 이용한 퍼옥시레독신의 샤페론 활성 조절방법
WO2012075911A1 (zh) * 2010-12-06 2012-06-14 Li Jianyuan 重组人prx-6蛋白在治疗烧烫伤和/或角膜损伤中的用途
CN102793911B (zh) * 2011-05-24 2015-12-16 李建远 重组人Prx-6蛋白在治疗角膜损伤方面的用途
CN106377764A (zh) * 2010-12-06 2017-02-08 李建远 重组人Prx‑6蛋白在治疗烧烫伤方面的用途
CN103417961B (zh) * 2012-05-23 2018-02-09 烟台聚杰生物工程有限公司 Prdx2和/或prdx6的新用途
CN105211054B (zh) * 2015-11-10 2017-05-24 刘娟 一种含重组人prdx4蛋白的人精液冷冻保护剂

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9612214D0 (en) * 1996-06-11 1996-08-14 Mallinckrodt Veterinary Inc Vaccine
EP1005360A4 (en) * 1997-04-02 2001-02-07 Jackson Lab ANTIOXIDANCE PROTEIN 2, GENES AND METHOD FOR USE THEREOF
BE1011331A6 (fr) * 1997-08-20 1999-07-06 Univ Catholique De Louvain Hal Polypeptide associe au peroxysome, sequence nucleotidique encodant ledit polypeptide et leur utilisation dans le diagnostic et/ou le traitement de maladies ou de lesions pulmonaires.
AR042572A1 (es) * 1999-04-02 2005-06-29 Sod Conseils Rech Applic Derivados de acido lipoico, procedimiento para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y utilizacion de dichos derivados para la preparacion de los referidos medicamentos
FR2798672B1 (fr) 1999-09-17 2003-10-31 Commissariat Energie Atomique Formes acides des peroxyredoxines et leur utilisation comme moyen de diagnostic
ATE538813T1 (de) * 2000-08-28 2012-01-15 Akira Awaya Serumthymischer faktor zur behandlung von oxidativem stress bei allergien
US20020168353A1 (en) * 2001-03-23 2002-11-14 Lynn Ralf Geiben Peroxiredoxin drugs for treatment of HIV-1 infection and methods of use thereof
WO2002061063A1 (en) * 2001-01-30 2002-08-08 Universite Catholique De Louvain Crystal structure of peroxiredoxin 5 and its use for design of structural homologues
EP1394182A1 (en) 2002-07-08 2004-03-03 Europroteome AG Agents and methods for diagnosis and therapy of cancer and cancer risk assessment
RU2250262C1 (ru) 2003-07-29 2005-04-20 Институт биоорганической химии им. академиков М.М.Шемякина и Ю.А.Овчинникова РАН РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pET23-a(+)PrxVIhumΔ178, КОДИРУЮЩАЯ N-КОНЦЕВОЙ ФРАГМЕНТ ПЕРОКСИРЕДОКСИНА VI ЧЕЛОВЕКА, И ШТАММ E.coli BL21/DE3/pET23-a(+)/PrxVIhumΔ178 - ПРОДУЦЕНТ N-КОНЦЕВОГО ФРАГМЕНТА ПЕРОКСИРЕДОКСИНА VI ЧЕЛОВЕКА
RU2280448C2 (ru) 2002-11-10 2006-07-27 Институт биофизики клетки РАН Композиция с антиоксидантными свойствами и способ лечения болезней млекопитающих
CA2532130C (en) * 2003-09-20 2016-07-19 Electrophoretics Limited Diagnostic method for brain damage-related disorders
KR100569165B1 (ko) 2003-11-14 2006-04-07 (주)아비코아생명공학연구소 닭 퍼옥시레독신 1 단백질 및 그를 코딩하는 핵산분자
KR100605308B1 (ko) 2003-12-01 2006-07-26 전남대학교산학협력단 ＰｒｘⅡ 단백질의 혈관 내피세포 탐지용 마아커로서의 용도
JP2008502891A (ja) * 2004-06-18 2008-01-31 エフ．ホフマン−ラ　ロシュ　アーゲー 乳癌のマーカーとしてのタンパク質ｐｄｘ１の使用
KR100953326B1 (ko) 2004-08-31 2010-04-20 이화여자대학교 산학협력단 페록시레독신의 활성검출 키트
KR100610774B1 (ko) * 2005-02-03 2006-08-28 이화여자대학교 산학협력단 퍼록시레독신 2 단백질을 유효성분으로 함유하는 혈관재협착 예방 및 치료용 약학조성물, 퍼록시레독신 2유전자 또는 그로부터 발현되는 단백질을 포함하는 혈관재협착 치료제 스크리닝용 조성물 및 이를 이용하는 혈관재협착 치료제 스크리닝 방법
WO2007140976A2 (en) 2006-06-06 2007-12-13 F. Hoffmann-La Roche Ag Enzymes as biomarker for alzheimer's disease
WO2008036835A2 (en) 2006-09-20 2008-03-27 Reddy Us Therapeutics Methods and compositions for upregulation of peroxiredoxin activity
JP2008275413A (ja) 2007-04-27 2008-11-13 Osaka Industrial Promotion Organization 扁平上皮癌の診断用キット及び判定方法

Similar Documents

Publication Publication Date Title
Lefevre et al. A novel and atypical type one interferon gene expressed by trophoblast during early pregnancy.
RS63050B1 (sr) Vakcine nukleinske kiseline
WO2005055948A3 (en) Epha2, epha4 and lmw-ptp and methods of treatment of hyperproliferative cell disorders
TW201406959A (zh) 抗發炎胜肽及包含其之成分（三）
KR20010006534A (ko) Ⅱ형 ｔｇｆ-베타 수용체／면역글로불린 불변 영역 융합 단백질
CN113563478A (zh) 白介素-4受体结合融合蛋白及其应用
US8377883B2 (en) Peptide for anti-angiogenesis and use thereof
JP2006505290A5 (enExample)
WO2004108088A3 (en) Methods and compositions for interferon therapy
CA2748392C (en) Use of interleukin-22 for the prevention and/or treatment of multiple organ dysfunction syndrome (mods)
AU2005323392B2 (en) Use of IL-22 for the treatment of conditions of metabolic disorders
SK287523B6 (sk) Použitie CC chemokínového mutanta, farmaceutický prostriedok s obsahom chemokínového mutanta, skrátený a mutovaný humánny RANTES a spôsob jeho výroby
US9839669B2 (en) Antiviral agent comprising recombinant mistletoe lectins
CN111848780A (zh) 一种IL-36的可溶性受体sIL-36R及其应用
ITRM950273A1 (it) Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni
CN111777667B (zh) 小肽及其在制备免疫调节药物中的应用
CN113501862A (zh) 一种多肽及其在制备免疫调节药物中的应用
CN107034201A (zh) 表观修饰酶setd2的抗病毒作用及其应用
CN108690123B (zh) 短肽在制备免疫调节药物中的应用
WO2017101089A1 (zh) 一种α促黑素细胞激素的融合蛋白及其制备方法和应用
US20140038887A1 (en) Glial cell line derived neurotrophic factor, obesity, and obesity-related diseases and conditions
KR101466875B1 (ko) 항종양괴사인자 수용체 2를 발현하도록 설계된 미니서클 벡터를 이용한 자가면역질환 치료
WO2002013845A3 (en) Inflammation related g-protein coupled receptor
US20180326009A1 (en) Glial Cell Line Derived Neurotrophic Factor, Obesity, and Obesity-Related Diseases and Conditions
CN117919385B (zh) IL-37在MERS-CoV感染疾病的治疗中的应用